Studies have revealed that P4HA2 upregulates the expression of PD-L1 in cervical cancer tissues and is negatively correlated with CD8+ T cells, regulating antitumor immunity and serving as a prognostic marker for immunotherapy (46). The gene discussed is P4HA2; the disease is cervical cancer.